A detailed history of Gamma Investing LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Gamma Investing LLC holds 3,910 shares of VRTX stock, worth $2.02 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
3,910
Previous 3,001 30.29%
Holding current value
$2.02 Million
Previous $1.41 Billion 29.28%
% of portfolio
0.18%
Previous 0.19%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$460.0 - $505.78 $418,140 - $459,754
909 Added 30.29%
3,910 $1.82 Billion
Q2 2024

Jul 02, 2024

BUY
$392.81 - $485.53 $327,210 - $404,446
833 Added 38.42%
3,001 $1.41 Billion
Q1 2024

Apr 05, 2024

BUY
$407.69 - $446.08 $66,453 - $72,711
163 Added 8.13%
2,168 $906 Million
Q4 2023

Feb 01, 2024

BUY
$343.0 - $410.68 $687,715 - $823,413
2,005 New
2,005 $869 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $133B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.